Pfizer (PFE) Gets a Hold Rating from J.P. Morgan

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $46. The company’s shares closed yesterday at $39.38. According to More »

The CEO of BioMarin Pharmaceutical Inc. is Exercising Options

Today it was reported that the CEO of BioMarin Pharmaceutical Inc. (BMRN – Research Report), Jean Jacques Bienaime, exercised options to buy 1,000 BMRN shares at $21.51 a share, for a total More »